These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 417106)

  • 1. [Prolactin. Its role in the hormone dependency of breast cancers].
    Hoff J; Hoff-Bardier M; Bayard F
    J Gynecol Obstet Biol Reprod (Paris); 1978 Jan; 7(1):19-30. PubMed ID: 417106
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolactin stimulation by thyrotropin-releasing hormone in a patient with isolated thyrotropin deficiency.
    Sachson R; Rosen SW; Cuatrecasas P; Roth J; Frantz AG
    N Engl J Med; 1972 Nov; 287(19):972-3. PubMed ID: 4627862
    [No Abstract]   [Full Text] [Related]  

  • 3. [TRH test in women with a breast epithelioma].
    Cappelaere P; Sulman C; Gosselin P; Demaille MC; Demaille A
    Lille Med; 1979; 24(7):518-22. PubMed ID: 120921
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prolactin. New findings and clinical significance].
    Horský J
    Cesk Gynekol; 1975 Mar; 40(2):148-53. PubMed ID: 805668
    [No Abstract]   [Full Text] [Related]  

  • 5. Human prolactin: secretion, regulation and pathophysiology.
    Yuen BH; Keye WR; Jaffe RB
    Obstet Gynecol Surv; 1973 Aug; 28(8):527-41. PubMed ID: 4216868
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor.
    Cook DM; Greer MA; Paxton H
    West J Med; 1987 Aug; 147(2):161-4. PubMed ID: 3116772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-releasing hormone is not the sole physiologic mediator of prolactin release during suckling.
    Gautvik KM; Tashjian AH; Kourides IA; Weintraub BD; Graeber CT; Maloof F; Suzuki K; Zuckerman JE
    N Engl J Med; 1974 May; 290(21):1162-5. PubMed ID: 4207375
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of growth hormone and prolactin secretion in patients with acromegaly and-or excessive prolactin secretion.
    Cryer PE; Jacobs LS; Daughaday WH
    Mt Sinai J Med; 1973; 40(3):402-13. PubMed ID: 4197309
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible linkage between the ability to change the period (tau) of the prolactin and cortisol rhythms in women and breast cancer risk.
    Lewy H; Haus E; Ashkenazi IE
    Chronobiol Int; 2007; 24(2):365-81. PubMed ID: 17453854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mastopathy and breast cancer: is there a typical hormone profile?].
    Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolactin and its clinical importance].
    Vasiukova EA; Pisarskaia IV
    Klin Med (Mosk); 1982 Mar; 60(3):9-15. PubMed ID: 6123615
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correlations between prolactin and somatotropic hormone in human breast cancer].
    Larrad Jiménez A; Caballero Asensi A; Estévez Molina M
    Rev Esp Oncol; 1980; 27(1):29-52. PubMed ID: 7209107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disordered nocturnal prolactin regulation in women with breast cancer.
    Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
    Cancer Res; 1977 Dec; 37(12):4650-4. PubMed ID: 922745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of parlodel and thyroliberin on prolactin secretion in patients with fibrocystic mastopathy].
    Sturia NT
    Probl Endokrinol (Mosk); 1983; 29(2):21-4. PubMed ID: 6406998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum prolactin and thyrotropin responses to thyrotropin releasing hormone during different phases of menstrual cycle in healthy women.
    Rastogi GK; Sialy R; Sawhney RC
    J Assoc Physicians India; 1976 Aug; 24(8):491-5. PubMed ID: 828905
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolactin and breast cancer.
    L'Hermite M; L'Hermite-Baleriaux M
    Eur J Cancer Clin Oncol; 1988 Jun; 24(6):955-8. PubMed ID: 3044802
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid-stimulating hormone and prolactin levels in breast cancer.
    Aldinger KA; Schultz PN; Blumenschein GR; Samaan NA
    Arch Intern Med; 1978 Nov; 138(11):1638-41. PubMed ID: 102267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prolactin. Physiology and physiopathology].
    Hagen C; Frøland A
    Ugeskr Laeger; 1978 Feb; 140(6):275-80. PubMed ID: 24910
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolactin and human breast cancer: a review.
    Nagasawa H
    Eur J Cancer (1965); 1979 Mar; 15(3):267-79. PubMed ID: 221222
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth hormone and prolactin release after injection of thyrotropin-releasing hormone in patients with depression.
    Maeda K; Kato Y; Ohgo S; Chihara K; Yoshimoto Y; Yamaguchi N; Kuromaru S; Imura H
    J Clin Endocrinol Metab; 1975 Mar; 40(3):501-5. PubMed ID: 803976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.